Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Three CDK inhibitors have been added to the interaction checker

Wednesday 06 February 2019

Abemaciclib, palbociclib and ribociclib  are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications.

  • Abemaciclib (Verzenio®, Verzenios®) is a CDK4 and CDK6 inhibitor and is indicated for the treatment of breast cancer.
  • Palbociclib (Ibrance®) is a CDK4 and CDK6 inhibitor and is indicated for the treatment of breast cancer.
  • Ribociclib (Kisqali®) is a CDK4 and CDK6 inhibitor and is indicated for the treatment of breast cancer.
ENDORSED BY
Bopa